Literature DB >> 21924324

Human adrenocortical carcinoma cell lines.

Tao Wang1, William E Rainey.   

Abstract

The human adrenal cortex secretes mineralocorticoids, glucocorticoids and adrenal androgens. These steroids are produced from unique cell types located within the three distinct zones of the adrenal cortex. Disruption of adrenal steroid production results in a variety of diseases that can lead to hypertension, metabolic syndrome, infertility and androgen excess. The adrenal cortex is also a common site for the development of adenomas, and rarely the site for the development of carcinomas. The adenomas can lead to diseases associated with adrenal steroid excess, while the carcinomas are particularly aggressive and have a poor prognosis. In vitro cell culture models provide important tools to examine molecular and cellular mechanisms controlling both the normal and pathologic function of the adrenal cortex. Herein, we discuss currently available human adrenocortical carcinoma cell lines and their use as model systems for adrenal studies. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21924324      PMCID: PMC3288152          DOI: 10.1016/j.mce.2011.08.041

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  72 in total

1.  Replicative senescence and differentiated gene expression in cultured adrenocortical cells.

Authors:  P J Hornsby; R F Ryan; C Y Cheng
Journal:  Exp Gerontol       Date:  1989       Impact factor: 4.032

2.  Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells.

Authors:  Lidia Cerquetti; Camilla Sampaoli; Donatella Amendola; Barbara Bucci; Laura Masuelli; Rodolfo Marchese; Silvia Misiti; Agostino De Venanzi; Maurizio Poggi; Vincenzo Toscano; Antonio Stigliano
Journal:  Exp Cell Res       Date:  2011-03-03       Impact factor: 3.905

3.  Adenovirus-delivered DKK3/WNT4 and steroidogenesis in primary cultures of adrenocortical cells.

Authors:  M Chen; P J Hornsby
Journal:  Horm Metab Res       Date:  2006-09       Impact factor: 2.936

4.  Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis.

Authors:  A F Gazdar; H K Oie; C H Shackleton; T R Chen; T J Triche; C E Myers; G P Chrousos; M F Brennan; C A Stein; R V La Rocca
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

5.  Suramin in adrenal cancer: modulation of steroid hormone production, cytotoxicity in vitro, and clinical antitumor effect.

Authors:  R V La Rocca; C A Stein; R Danesi; C A Jamis-Dow; G H Weiss; C E Myers
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

6.  Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome.

Authors:  D E Schteingart; T J Giordano; R S Benitez; M D Burdick; M N Starkman; D A Arenberg; R M Strieter
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

7.  Differential regulation of 11 beta-hydroxylase and aldosterone synthase in human adrenocortical H295R cells.

Authors:  K Denner; W E Rainey; V Pezzi; I M Bird; R Bernhardt; J M Mathis
Journal:  Mol Cell Endocrinol       Date:  1996-07-23       Impact factor: 4.102

8.  Peroxisome proliferator-activated receptor-{gamma} suppresses CYP11B2 expression and aldosterone production.

Authors:  Akira Uruno; Ken Matsuda; Naoya Noguchi; Takeo Yoshikawa; Masataka Kudo; Fumitoshi Satoh; William E Rainey; Xiao-Gang Hui; Jun-ichi Akahira; Yasuhiro Nakamura; Hironobu Sasano; Hiroshi Okamoto; Sadayoshi Ito; Akira Sugawara
Journal:  J Mol Endocrinol       Date:  2011-01-19       Impact factor: 5.098

Review 9.  TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation.

Authors:  S Bandulik; D Penton; J Barhanin; R Warth
Journal:  Horm Metab Res       Date:  2010-01-04       Impact factor: 2.936

10.  WNT-4 mRNA expression in human adrenocortical tumors and cultured adrenal cells.

Authors:  T Kuulasmaa; J Jääskeläinen; S Suppola; T Pietiläinen; P Heikkilä; S Aaltomaa; V-M Kosma; R Voutilainen
Journal:  Horm Metab Res       Date:  2008-06-13       Impact factor: 2.936

View more
  49 in total

1.  Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.

Authors:  Silvia Monticone; Namita G Hattangady; Koshiro Nishimoto; Franco Mantero; Beatrice Rubin; Maria Verena Cicala; Raffaele Pezzani; Richard J Auchus; Hans K Ghayee; Hirotaka Shibata; Isao Kurihara; Tracy A Williams; Judith G Giri; Roni J Bollag; Michael A Edwards; Carlos M Isales; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2012-05-24       Impact factor: 5.958

2.  Effects of combination treatment with sirolimus and mitotane on growth of human adrenocortical carcinoma cells.

Authors:  Maria Cristina De Martino; Peter M van Koetsveld; Richard A Feelders; Steven W J Lamberts; Wouter W de Herder; Annamaria Colao; Rosario Pivonello; Leo J Hofland
Journal:  Endocrine       Date:  2015-12-08       Impact factor: 3.633

3.  Contemporary preclinical human models of adrenocortical carcinoma.

Authors:  Emilia Modolo Pinto; Katja Kiseljak-Vassiliades; Constanze Hantel
Journal:  Curr Opin Endocr Metab Res       Date:  2019-08-29

4.  Calpain-10 Activity Underlies Angiotensin II-Induced Aldosterone Production in an Adrenal Glomerulosa Cell Model.

Authors:  Mutsa Seremwe; Rick G Schnellmann; Wendy B Bollag
Journal:  Endocrinology       Date:  2015-04-02       Impact factor: 4.736

5.  M3-subtype muscarinic receptor activation stimulates intracellular calcium oscillations and aldosterone production in human adrenocortical HAC15 cells.

Authors:  Latha M Malaiyandi; Harsh Sharthiya; Nuntida Surachaicharn; Yara Shams; Mohammad Arshad; Chad Schupbach; Phillip G Kopf; Kirk E Dineley
Journal:  Mol Cell Endocrinol       Date:  2018-06-28       Impact factor: 4.102

6.  EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression.

Authors:  Coralie Drelon; Annabel Berthon; Mickael Mathieu; Bruno Ragazzon; Rork Kuick; Houda Tabbal; Amandine Septier; Stéphanie Rodriguez; Marie Batisse-Lignier; Isabelle Sahut-Barnola; Typhanie Dumontet; Jean-Christophe Pointud; Anne-Marie Lefrançois-Martinez; Silvère Baron; Thomas J Giordano; Jérôme Bertherat; Antoine Martinez; Pierre Val
Journal:  Hum Mol Genet       Date:  2016-05-05       Impact factor: 6.150

7.  Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene.

Authors:  S G Creemers; P M van Koetsveld; E S R van den Dungen; E Korpershoek; F J van Kemenade; G J H Franssen; W W de Herder; R A Feelders; L J Hofland
Journal:  J Clin Endocrinol Metab       Date:  2016-09-07       Impact factor: 5.958

8.  Development of monoclonal antibodies against human CYP11B1 and CYP11B2.

Authors:  Celso E Gomez-Sanchez; Xin Qi; Carolina Velarde-Miranda; Maria W Plonczynski; C Richard Parker; William Rainey; Fumitoshi Satoh; Takashi Maekawa; Yasuhiro Nakamura; Hironobu Sasano; Elise P Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2013-12-08       Impact factor: 4.102

9.  Angiotensin II and III metabolism and effects on steroid production in the HAC15 human adrenocortical cell line.

Authors:  Kenji Oki; Phillip G Kopf; William B Campbell; Milay Luis Lam; Takeshi Yamazaki; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-12-07       Impact factor: 4.736

10.  Age-dependent Increases in Adrenal Cytochrome b5 and Serum 5-Androstenediol-3-sulfate.

Authors:  Juilee Rege; Shigehiro Karashima; Antonio M Lerario; Joshua M Smith; Richard J Auchus; Josephine Z Kasa-Vubu; Hironobu Sasano; Yasuhiro Nakamura; Perrin C White; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2016-09-13       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.